Global Synthetic Biology Market Insights Forecasts to 2033

• The Global Synthetic Biology Market Size was Valued at USD 14.3 Billion in 2023
• The Market Size is Growing at a CAGR of 25.57% from 2023 to 2033
• The Worldwide Synthetic Biology Market Size is Expected to Reach USD 139.4 Billion by 2033
• Asia-Pacific is Expected to Grow the fastest during the forecast period.

The Global Synthetic Biology Market Size is Anticipated to Exceed USD 139.4 Billion by 2033, Growing at a CAGR of 25.57% from 2023 to 2033.

Market Overview

The process of generating new biological entities, such as cells, enzymes, and genetic circuits, and altering already-existing biological systems is known as synthetic biology. Engineering and science combine in synthetic biology to generate novel biological systems with useful applications. The primary goal of synthetic biology is to produce novel biological substances, such as advanced biofuels, renewable chemicals, and bioproducts that are not found in nature. Standardized genomic units are seen by synthetic biology, which can be used to quickly synthesize and assemble small genomic components into integrated big systems to address particular biological problems for developing biological systems.

Several factors drive the industry, including increased funding for drug discovery R&D, enhanced support from the government and corporate sectors, and decreased costs and advancements in DNA sequencing and synthesizing. Furthermore, key market players include Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Novozymes, Ginkgo Bioworks, and Amyris GenScript. During the forecast period, the demand is expected to be driven by the expanding scope of synthetic biology applications for therapeutic genome editing, cellular recording, and multiplexed diagnostics.

For instance, in May 2024, Ginkgo Bioworks, constructing the industry-leading platform for cell programming and biosecurity, and Sojitz, a sizable Japanese general trading company with broad networks across the Japanese economy, announced that they have reached a legally-binding, definitive agreement. Along with promoting the application of synthetic biology to the development of sustainable industrial methods, Sojitz and Ginkgo hope to develop relationships with important Japanese companies.

Report Coverage

This research report categorizes the market for the global synthetic biology market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global synthetic biology market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global synthetic biology market.

Driving Factors

The decreasing supply of the antibiotic pipeline, the increased prevalence of chronic and destroying diseases like cancer and HIV, and the growing need to find effective and promising treatments for several diseases that significantly decrease people's quality of life worldwide have all contributed to the acceleration of synthetic biomedicine research. The market is expanding due in part to government organizations' ongoing increases in financing for synthetic biology. The company concentrates on making investments in the biotechnology and healthcare industries. The financing helped the imperial-hosted center to maintain its support for small and startup businesses engaged in synthetic biology, bolster the developing economy in the UK, and assist in realizing the benefits of synthetic biology for society. The market is expected to grow in response to the increasing need for customized medicine, protein treatments, and research on artificial pharmaceuticals and vaccines.

Restraining Factors

The intentional or accidental release of synthetic organisms into the environment during research and other uses is a major biosafety risk in synthetic biology. Released into the environment, synthetic bacteria have the potential to mutate or interact with other organisms, contributing to the cross-breeding of natural creatures and the creation of bioerrors. The ecosystem of natural organisms might be damaged by this. Another significant biosafety obstacle is the emergence of superbugs that are resistant to antibiotics.

Market Segmentation

The global synthetic biology market share is classified into product, technology, and application.

• The oligonucleotide/oligo pools and synthetic DNA segment are expected to hold the largest share of the synthetic biology market during the forecast period.   

Based on the product, the global synthetic biology market is divided into enzymes, oligonucleotide/oligo pools and synthetic DNA, xeno-nucleic acids, and cloning technologies kits. Among these, the oligonucleotide/oligo pools and synthetic DNA segment is expected to hold the largest share of the global synthetic biology market during the forecast period. In many applications related to molecular biology and synthesis, oligonucleotides are the main component. The main factors driving this market include the growing use of CRISPR gene editing, DNA computing, mutagenesis research, and targeted NGS. For instance, oligomix is an innovative and customized approach to genomics research that greatly accelerates the synthesis of many oligonucleotide sequences in immediately. 

• The PCR technology segment is expected to hold the largest share of the synthetic biology market during the forecast period.   

Based on the technology, the global synthetic biology market is divided into PCR technology, NGS technology, bioprocessing technology, genome editing technology, and other technologies. Among these, the PCR technology segment is expected to hold the largest share of the synthetic biology market during the forecast period. One of the most important technologies for identifying and examining certain gene sequences is polymerase chain reaction, or PCR. In the majority of PCR-based genomic research, real-time PCR assays are the favored approach due to their exceptional sensitivity and specificity. The technique is frequently applied in the fields of genomics, DNA cloning, molecular diagnostics, and forensic analysis. 

• The healthcare segment is expected to hold the largest share of the global synthetic biology market during the forecast period. 

Based on the application, the global synthetic biology market is divided into healthcare and non-healthcare. Among these, the healthcare segment is expected to hold the largest share of the global synthetic biology market during the forecast period. Diagnostics based on synthetic biology provide a real-time, non-invasive, highly specific, sensitive approach to identifying drugs, cancer cells, and infectious microorganisms. Researchers develop dynamic biosensing systems using sensors, processors, and reporters using rational engineering techniques.

Regional Segment Analysis of the Global Synthetic Biology Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global synthetic biology market over the predicted timeframe.

North America is anticipated to hold the largest share of the global synthetic biology market over the predicted timeframe. The United States is leading the expansion of the synthetic biology market with research mostly focused on proteomics, drug screening & discovery, and genome structure prediction. Due mostly to significant investments made in research and development by well-known biotechnology businesses with headquarters in the United States and Canada, North America has emerged as the leading region in the worldwide synthetic biology industry. Leaders in the field of synthetic biology technologies worldwide, the region is home to cutting-edge techniques in synthetic biology that are being used to produce sophisticated gene and cell therapies. Innovations and translational research have been accelerated in the region by the presence of significant academic research institutes and government support for synthetic biology research through programs like NIH.

Asia-Pacific is expected to grow at the fastest pace in the global synthetic biology market during the forecast period. The rapidly rising economies such as China and India in the Asia Pacific area are creating favorable conditions for the biotechnology sector to flourish. Through programs like GIDL projects, China, in particular, has demonstrated concentrated and well-coordinated efforts to become a leader in synthetic biology. In addition, the region's cost competitiveness for manufacturing and highly qualified scientific personnel are drawing international businesses to set up R&D centers and manufacturing facilities there. During the forecast period, the Asia Pacific synthetic biology market will be driven by the rising need for biopharmaceuticals and healthcare.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global synthetic biology market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Merck KGaA
• Agilent Technologies
• Novozymes
• Ginkgo Bioworks
• Genscript
• Thermo Fisher Scientific Inc
• Amyris Inc
• Integrated DNA Technologies Inc.
• Illumina, Inc.
• Precigen, Inc.
• Twist Bioscience
• Synthetic Genomics
• Codexis
• Synthego
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In February 2024, bit. Bio was named the first partnership of the Ginkgo Technology Network by bit. bio and Ginkgo Bioworks. After its launch, the Network is a ground-breaking network of innovative technology partners dedicated to working with Ginkgo to offer fresh, integrated capabilities that will boost the success of client R&D projects.

• In January 2024, the goal of the Rice Synthetic Biology Institute, launched by Rice University of the United States, is to spur cooperative research in synthetic biology and its application to technologies that advance society.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global synthetic biology market based on the below-mentioned segments: 

Global Synthetic Biology Market, By Product

• Enzymes
• Oligonucleotide/Oligo Pools and Synthetic DNA
• Xeno-Nucleic Acids
• Cloning Technologies Kits

Global Synthetic Biology Market, By Technology

• PCR Technology
• NGS Technology
• Bioprocessing Technology
• Genome Editing Technology
• Other Technologies

Global Synthetic Biology Market, By Application

• Healthcare
• Non-healthcare

Global Synthetic Biology Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa